Pharma Journalist 8801 posts 0 comments

ISA Pharmaceuticals B.V., a private clinical-stage immunotherapy company, announced plans to initiate a potentially pivotal clinical trial for the combination of ISA101b and Libtayo…
Read More...

Lassen Therapeutics announced it has emerged from stealth and secured $31 million in Series A financing to develop antibodies as potential treatments for fibrosis, rare diseases and…
Read More...

PDS Biotechnology Corporation announced a co-development agreement with Farmacore Biotechnology for Versamune-CoV-2FC, a Versamune-based vaccine aimed at preventing COVID-19 infection.…
Read More...

Jazz Pharmaceuticals plc announced along with its partner PharmaMar that the U.S. Food and Drug Administration (FDA) approved Zepzelca (lurbinectedin) for the treatment of adult…
Read More...

Merck, known as MSD outside the United States and Canada, and Pfizer Inc. announced the presentation of results from the Phase 3 VERTIS CV cardiovascular (CV) outcomes trial that…
Read More...

IDEAYA Biosciences, Inc. and GlaxoSmithKline plc (GSK) announce a strategic partnership in Synthetic Lethality, an emerging field in Oncology. The strategic partnership includes…
Read More...

Sanofi detailed plans on how the Company will make significant investments in France to increase its vaccines research and production capacities, and contribute in responding to future…
Read More...

London – Arena International announced today the first ever Direct-to-Patient and Virtual Clinical Trials (https://arena-international.com/dtpvirtual/) will be held as a Digital…
Read More...

Monopar Therapeutics Inc. and NorthStar Medical Radioisotopes, LLC (Beloit, WI) announced a 50/50 collaboration to develop potential Radio-Immuno-Therapeutics (RITs) to treat severe…
Read More...

Eli Lilly and Company announced that the first patient has been enrolled in a Phase 3 randomized, double-blind, placebo–controlled study to evaluate the efficacy and safety of…
Read More...